← Back to Charities
Australasian Gastro-Intestinal Trials Group
LargeHPC
Revenue
$21.8M
Total Assets
$30.2M
Staff FTE
20
Volunteers
160
About
It serves general community, other, chronic illness.
ACNC Financial History
| Year | Revenue | Expenses | Assets | Staff |
|---|---|---|---|---|
| FY2023 | $21.8M | $21.0M | $30.2M | 20 FTE + 160 vol |
| FY2022 | $16.7M | $17.2M | $26.7M | 16 FTE + 160 vol |
| FY2021 | $15.3M | $14.3M | $23.5M | 15 FTE + 85 vol |
| FY2020 | $10.2M | $7.3M | $17.5M | 11 FTE + 60 vol |
| FY2019 | $8.4M | $9.6M | $13.9M | 10 FTE + 120 vol |
| FY2018 | $5.3M | $5.8M | $13.5M | 7 FTE + 110 vol |
| FY2017 | $5.8M | $7.1M | $13.6M | 10 FTE + 4 vol |
| 7yr history | Source: ACNC Annual Information Statements | |||
Focus Areas
Beneficiaries
General CommunityOtherChronic Illness
Is this your organisation?
Claim this profile to update your information, share your story, and get featured.
Claim This Profile